HPP-737

N/A

Report date: 2024/04/17 13:38:09
NME

Base Information

Drug NameHPP-737
Drug Alias NameHPP-737
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphodieterase 4 inhibitors
TargetsPhosphodieterase 4
Therapy Area/IndicationsPlaque psoriasisPsoriasisDermatitis, Atopic +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesVtv Therapeutics
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesJumpcan Pharmaceutical Group Co LtdHengyi Biomedical Technology (Shanghai) Co Ltd
Inactive CompaniesNewsoara Biopharma Co Ltd
Active IndicationsPlaque psoriasisPsoriasisDermatitis, Atopic +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A